-
Why CBD and Skin? The Science of Skincare
THE SCIENCE OF SKINCARE / Why CBD and Skin? The benefits of using CBD in skincare products are often understated. We're clearing the air about why we think CBD is a must-have in all topical products. Antioxidant CBD is a more powerful antioxidant than Vitamin C, E, or A (9). This antioxidant property of CBD (and other cannabinoids) fights free radical damage and stimulates recovery from oxidative stress (9). Without antioxidants as a part of your skin care routine, oxidative stress can break down collagen, hinder skin’s natural repair process, and trigger inflammation. You’ll often see the effect...THE SCIENCE OF SKINCARE / Why CBD and Skin? The benefits of using CBD in skincare products are often understated. We're clearing the air about why we think CBD is a must-have in all topical products. Antioxidant CBD is a more powerful antioxidant than Vitamin C, E, or A (9). This antioxidant property of CBD (and other cannabinoids) fights free radical damage and stimulates recovery from oxidative stress (9). Without antioxidants as a part of your skin care routine, oxidative stress can break down collagen, hinder skin’s natural repair process, and trigger inflammation. You’ll often see the effect... -
The Human Endocannabinoid System (ECS)
-
THE DISCOVERY OF THE ENDOCANNABINOID SYSTEM - CENTURIES IN THE MAKING
Newswise — For more insight into the history of cannabinoid and endocannabinoid research, listen to an interview with Raphael Mechoulam and Mier Bialer, recorded at the 13th European Congress on Epileptology in August 2018. Recently, cannabis has experienced a resurgence of interest. Two countries—Uruguay and Canada—have legalized it. In the United States, 33 states and the District of Columbia now allow at least its medical use. In the field of epilepsy, there have been more than 150 years of anecdotes about the plant’s anti-seizure effects. Recent trials of cannabidiol (CBD)—a molecule found in the cannabis plant—led to the...Newswise — For more insight into the history of cannabinoid and endocannabinoid research, listen to an interview with Raphael Mechoulam and Mier Bialer, recorded at the 13th European Congress on Epileptology in August 2018. Recently, cannabis has experienced a resurgence of interest. Two countries—Uruguay and Canada—have legalized it. In the United States, 33 states and the District of Columbia now allow at least its medical use. In the field of epilepsy, there have been more than 150 years of anecdotes about the plant’s anti-seizure effects. Recent trials of cannabidiol (CBD)—a molecule found in the cannabis plant—led to the...